243 related articles for article (PubMed ID: 28837800)
1. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
3. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
[TBL] [Abstract][Full Text] [Related]
4. Effect of retinoic acid in experimental diabetic nephropathy.
Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
6. Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy.
Du Q; Fu YX; Shu AM; Lv X; Chen YP; Gao YY; Chen J; Wang W; Lv GH; Lu JF; Xu HQ
Life Sci; 2021 May; 272():118808. PubMed ID: 33245967
[TBL] [Abstract][Full Text] [Related]
7. Fasting mimicking diet in diabetic mice partially preserves glomerular endothelial glycocalyx coverage, without changing the diabetic metabolic environment.
van der Velden AIM; Koudijs A; Kooijman S; Rietjens RGJ; Sol WMPJ; Avramut MC; Wang G; Rensen PCN; Rabelink TJ; van der Vlag J; van den Berg BM
Am J Physiol Renal Physiol; 2024 May; 326(5):F681-F693. PubMed ID: 38205540
[TBL] [Abstract][Full Text] [Related]
8. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
[TBL] [Abstract][Full Text] [Related]
9. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
10. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
Zhang LN; Xie XS; Zuo C; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
[TBL] [Abstract][Full Text] [Related]
12. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.
Menne J; Eulberg D; Beyer D; Baumann M; Saudek F; Valkusz Z; Więcek A; Haller H;
Nephrol Dial Transplant; 2017 Feb; 32(2):307-315. PubMed ID: 28186566
[TBL] [Abstract][Full Text] [Related]
13. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.
Darisipudi MN; Kulkarni OP; Sayyed SG; Ryu M; Migliorini A; Sagrinati C; Parente E; Vater A; Eulberg D; Klussmann S; Romagnani P; Anders HJ
Am J Pathol; 2011 Jul; 179(1):116-24. PubMed ID: 21703397
[TBL] [Abstract][Full Text] [Related]
15. Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy.
Boels MG; van Faassen EE; Avramut MC; van der Vlag J; van den Berg BM; Rabelink TJ
PLoS One; 2017; 12(1):e0170065. PubMed ID: 28103268
[TBL] [Abstract][Full Text] [Related]
16. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
[TBL] [Abstract][Full Text] [Related]
17. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
Awad AS; You H; Gao T; Cooper TK; Nedospasov SA; Vacher J; Wilkinson PF; Farrell FX; Brian Reeves W
Kidney Int; 2015 Oct; 88(4):722-33. PubMed ID: 26061548
[TBL] [Abstract][Full Text] [Related]
19. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.
Awad AS; Kinsey GR; Khutsishvili K; Gao T; Bolton WK; Okusa MD
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1358-66. PubMed ID: 21880831
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
